Simon Noble (@simonnoble) 's Twitter Profile
Simon Noble

@simonnoble

Marie Curie Professor in Supportive and Palliative Medicine. Director Division of Population Medicine, Cardiff University.

ID: 20306538

calendar_today07-02-2009 12:24:34

9,9K Tweet

3,3K Followers

1,1K Following

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Dr. Mahé Isabelle on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE #ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag

Dr. <a href="/isabellemahe1/">Mahé Isabelle</a> on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE

#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag
Oncology News Central (@oncnewscentral) 's Twitter Profile Photo

Study API-CAT: Low-dose apixaban proved noninferior to full-dose for extended #VTE prevention in active cancer—with significantly less bleeding. Practice-changing. bit.ly/3E4UxFk #ACC25 #Oncology Mahé Isabelle Diego Sadler MD FACC Simon Noble NEJM

Marie Curie Research Centre, Cardiff (@mcpcrccardiff) 's Twitter Profile Photo

The Death Literacy Research Network led by Dr Michelle Edwards are having their first webinar on the 23rd May to explore ways of understanding death literacy in Wales. Register with the link below: events.teams.microsoft.com/event/c9c018fa…

The Death Literacy Research Network led by Dr Michelle Edwards are having their first webinar on the 23rd May to  explore ways of understanding death literacy in Wales. Register with the link below:
events.teams.microsoft.com/event/c9c018fa…
Emily Harrop (@emilyharrop10) 's Twitter Profile Photo

Did you (or someone you know) care for a terminally ill family member who died when you were aged 25 or under? If so please consider taking part in one of our online focus groups to help us improve support for young carers. Pls contact me on [email protected]. Many thanks!

Did you (or someone you know) care for a terminally ill family member who died when you were aged 25 or under? If so please consider taking part in one of our online focus groups to help us improve support for young carers. Pls contact me on harrope@cardiff.ac.uk. Many thanks!
Simon Noble (@simonnoble) 's Twitter Profile Photo

High level academic meeting with ⁦Alex Tonks⁩. In 30 minutes we managed to sort out the school finances, curriculum and REF. #leadership #collaboration #fibs

High level academic meeting with ⁦<a href="/alex_tonks/">Alex Tonks</a>⁩. In 30 minutes we managed to sort out the school finances, curriculum and REF. #leadership #collaboration #fibs
Vasculearn Network (@vasculearn) 's Twitter Profile Photo

💜 How we talk about blood clots matters. 💜 🏥 The VTE Communication Guide was created to help clinicians navigate the complex conversations that follow a venous thromboembolism (VTE) diagnosis from risk and treatment to emotions and uncertainty. ❤️ This project brings

💜 How we talk about blood clots matters. 💜 

🏥 The VTE Communication Guide was created to help clinicians navigate the complex conversations that follow a venous thromboembolism (VTE) diagnosis from risk and treatment to emotions and uncertainty.   

❤️ This project brings
Pippa Britton PLY (@pippabritton) 's Twitter Profile Photo

These are the 'seats' for wheelchair users for a 3 hour+ train journey to Manchester. No seat to transfer into. No table for a cup of coffee or laptop to work. New trains should be better than this Trafnidiaeth Cymru Trenau Transport for Wales Rail Tanni Grey-Thompson

These are the 'seats' for wheelchair users for a 3 hour+ train journey to Manchester. No seat to transfer into. No table for a cup of coffee or laptop to work. New trains should be better than this <a href="/tfwrail/">Trafnidiaeth Cymru Trenau Transport for Wales Rail</a> <a href="/Tanni_GT/">Tanni Grey-Thompson</a>
Mary Cushman 🫀🧠🩸 (@marycushmanmd) 's Twitter Profile Photo

Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

Is this the end of rivaroxaban for acute VTE?
<a href="/LanaCastellucci/">Lana Castellucci</a> presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 
56% reduction in bleeding risk with apixaban. 
A safer Rx with the same efficacy. 
#ISTH2025
Tzu-Fei Wang (@tzufeiwang) 's Twitter Profile Photo

Hot off the press! COBBRA trial showed that apixaban is associated with >50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing! Lana Castellucci Marc Rodger CanVECTOR Network

Hot off the press! COBBRA trial showed that apixaban is associated with &gt;50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing!
<a href="/LanaCastellucci/">Lana Castellucci</a> <a href="/RodgerMarc/">Marc Rodger</a> <a href="/canvector/">CanVECTOR Network</a>
Cathy Harrison 💙 (@cathyah1980) 's Twitter Profile Photo

Incredibly interesting, mixed methods study on antithrombotic therapy (ATT) during advanced cancer care. Experienced clinicians we're more likely to deprescribe ATT & patient choice was a key decision maker in that action #SERENITY #Antithrombotic #anticoagulation #ISTH2025

Incredibly interesting, mixed methods study on antithrombotic therapy (ATT) during advanced cancer care. Experienced clinicians we're more likely to deprescribe ATT &amp; patient choice was a key decision maker in that action #SERENITY #Antithrombotic #anticoagulation #ISTH2025